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Abstract
Background: Late stage diagnosis of oesophageal and gastric cancer is common, which limits 
treatment options and contributes to poor survival.
Aim: To explore patients' understanding, experience and presentation of symptoms before a diagnosis 
of oesophageal or gastric cancer.
Design & setting: Between May 2016 and October 2017, all patients newly diagnosed with 
oesophageal or gastric cancer were identified at weekly multidisciplinary team meetings at two large 
hospitals in England. A total of 321 patients were invited to participate in a survey and secondary care 
medical record review; 127 (40%) participants responded (102 patients had oesophageal cancer and 
25 had gastric cancer). Of these, 26 participated in an additional face- to- face interview.
Method: Survey and medical record data were analysed descriptively. Interviews were analysed using 
thematic analysis, informed by the Model of Pathways to Treatment.
Results: Participants experienced multiple symptoms before diagnosis. The most common symptom 
associated with oesophageal cancer was dysphagia (n = 66, 65%); for gastric cancer, fatigue or 
tiredness (n = 20, 80%) was the most common symptom. Understanding of heartburn, reflux and 
indigestion, and associated symptoms differed between participants and often contrasted with 
clinical perspectives. Bodily changes attributed to personal and/or lifestyle factors were self- 
managed, with presentation to primary care prompted when symptoms persisted, worsened, or 
impacted daily life, or were notably severe or unusual. Participants rarely presented all symptoms at 
the initial consultation.
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Conclusion: The patient interval may be lengthened by misinterpretation of key terms, such as 
heartburn, or misattribution or non- recognition of important bodily changes. Clearly defined symptom 
awareness messages may encourage earlier help- seeking, while eliciting symptom experience and 
meanings in primary care consultations could prompt earlier referral and diagnosis.
How this fits in
Approximately 70% of oesophageal and gastric cancers are diagnosed at a late stage, contributing 
to poor survival outcomes observed for these cancers. There is limited evidence exploring the 
pathways to diagnosis from the patient’s perspective; this study highlights the multiple symptoms 
typically experienced before help- seeking in primary care. Some differences were identified in 
symptom experience between patients newly diagnosed with oesophageal or gastric cancer, and 
there was variation in patient understanding of key terms such as heartburn, reflux and indigestion, 
and the symptoms associated with these conditions. The results highlight the importance of exploring 
symptom understanding and experience with patients in primary care to avoid missed opportunities 
for timely diagnosis.
Introduction
Oesophageal and gastric cancers, often referred to as oesophago- gastric cancers, account for 5% of 
all new cancer cases in the UK, with over 15 000 cases diagnosed in 2015.1,2 Approximately 70% are 
diagnosed at a late stage (III or IV),1,2 and less than 20% of patients are alive after 5 years.3,4 An analysis 
of cancer diagnosis audit data identified that patients with oesophageal cancer experienced a median 
patient interval, the time between symptom onset and presentation in primary care, of 21.5 days 
(interquartile range [IQR] 7–46; gastric median 9 days, IQR 0–38), while patients with gastric cancer 
experienced a longer primary care interval, from presentation to referral (median 12 days, IQR 0–65; 
oesophageal median 5 days, IQR 0–30).5
Motivated by a policy commitment to achieve earlier cancer diagnoses and reduce mortality,6 
the 2015 Be Clear on Cancer campaign highlighted potential oesophago- gastric cancer symptoms, 
encouraging people to seek medical advice for recurrent heartburn or difficulty swallowing 
(dysphagia).7 Although evidence suggests that heartburn is associated with earlier stage oesophageal 
cancer,8 patients may not understand the term ‘heartburn’9 and, while urgent referral from primary 
care is recommended for all patients presenting with dysphagia,10 this symptom is often associated 
with later stage disease.11,12 An evaluation of the pilot study in the north of England demonstrated a 
significant increase in cancers diagnosed in those aged 60–69 years13 during the campaign period; 
however, these findings were not replicated in the national campaign.14,15
While dysphagia is considered an ‘alarm symptom’, prompting urgent referral for suspected 
cancer,10 other symptoms presented to primary care can be similar to benign gastrointestinal 
disorders.16 Clinician symptom assessment does not always match patients’17 and misattribution of 
symptoms could be contributing to up to a third of patients requiring three or more primary care 
consultations before referral.18
There is little patient- reported data on how people appraise and seek help for possible symptoms 
of oesophageal or gastric cancer, to underpin efforts to encourage earlier diagnosis. The aim of this 
study was, therefore, to explore patient’s understanding, experience, and presentation of symptoms 
before diagnosis.
Method
A multi- method approach was used, which comprised a patient survey, secondary care case- note 
review, and semi- structured patient interviews.
Recruitment
Eligible patients (aged ≥18 years, newly diagnosed with oesophageal or gastric cancer) were 
identified at weekly regional upper gastrointestinal multidisciplinary team meetings at two large 
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hospitals in the east and north east of England from May 2016–October 2017. Research or specialist 
nurses approached eligible patients within 4 weeks of diagnosis where possible, through face- 
to- face or postal contact. Patients received an information sheet, study questionnaire, consent 
form, and freepost envelope to return completed documents to the study team, with the option 
to participate by phone. Patients assessed as ineligible by their diagnosing clinician (for example, 
serious comorbidities, unable to communicate in English) were excluded. Non- responders were not 
sent reminders.
Participants willing to be interviewed were purposively sampled by age, sex, cancer type, and 
region (east or north east) for a face- to- face interview conducted within 10 weeks of diagnosis (June 
2016–July 2017) at a location chosen by the participant. Written informed consent was obtained 
before participation.
Data collection
The study questionnaire used previously validated items from the SYMPTOM UK cohort studies19–21 
to gather data on symptom onset and first presentation to the GP (free- text response and dates). 
An item from the 2014 National Cancer Patient Experience Survey22 determined the number of pre- 
referral GP consultations. Newly developed items explored medication use before diagnosis, along 
with symptom experience, and frequency (all or most of the time, some of the time, rarely, or never) 
based on a list of 12 symptoms (Box 1A). Items on education, living arrangements, ethnic group, sex, 
and comorbidities were also included. The questionnaire was assessed for face validity and usability in 
a think- aloud study23,24 with eight participants, with minor modifications made before use in the main 
study.
Interviews were conducted by one researcher, with experience of qualitative research, using a 
semi- structured topic guide (Box 1B) developed for the study and informed by previous qualitative 
studies.25–27 A calendar landmarking approach28,29 aided event recall. All interviews were audio- 
recorded (duration 42–111 minutes) and transcribed verbatim. Memos were used to reflect on 
interviews.
Secondary care medical records confirmed each participant’s pre- treatment disease stage and 
histological diagnosis (date and findings).
a: symptoms explored in the questionnaire
•	 Burning	feeling	behind	your	breastbone	(heartburn)
•	 Stomach	contents	moving	upwards	to	your	throat	or	mouth	(regurgitation)
•	 Liquid	or	food	sticking	when	you	swallow	(dysphagia)
•	 Pain	when	you	swallow	(pain	swallowing)
•	 Pain	or	tenderness	in	the	upper	part	of	your	stomach	(upper	abdominal	pain)
•	 Fullness	or	bloating	in	the	upper	part	of	your	stomach	(fullness	or	bloating)
•	 Decrease	in	appetite	(decreased	appetite)
•	 Nausea
•	 Vomiting
•	 Vomiting	blood
•	 Unexplained	weight	loss	(weight	loss)
•	 Fatigue	or	tiredness
B: Key areas of the interview topic guide
1.	 Introduction	—	study	overview,	data	protection	and	confidentiality,	consent,	any	questions
2.	 Opening	question	—	encourage	participants	to	talk	about	themselves,	explore	daily	life	prior	to	the	symptoms	or	diagnosis,	familiarise	with	
participant’s	social	network
3.	 Symptom	experience	—	exploration	of	bodily	changes	and	symptom	experiences,	timeline	of	events,	appraisal	of	symptoms,	prior	
knowledge,	information-	seeking,	symptom	management,	social	influence
4.	 Healthcare	experience	—	help-	seeking,	exploration	of	first	consultation,	subsequent	consultations,	timeline	of	events,	relationship	with	
healthcare	provider,	opinions	about	the	consultation(s),	thoughts	and	feelings	about	the	diagnosis
5.	 Interview	close	—	confirmation	of	data	protection	and	confidentiality,	any	questions,	thanks
(	)	Symptom	abbreviation	for	reporting	purpose
Box 1  Questionnaire and interview items
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Analysis
Survey data were imported to IBM SPSS (version 25) and analysed descriptively to explore participant 
characteristics (cancer type, age, sex, ethnic group, and region), comorbidities, symptoms (total 
cohort and by cancer type), and healthcare experience before diagnosis (over- the- counter medication, 
reported GP consultations, and referral route), and pre- treatment disease stage. The time between 
first noticing and first reporting a symptom to the GP was calculated using participant- reported exact 
or estimated dates (2- year timeframe), with analysis rules from previous studies used to convert the 
latter to estimated exact dates.19–21 Pearson’s χ2 test was used to evaluate non- response based on 
age and sex.
Interview audio files were professionally transcribed and transcripts uploaded to NVivo (version 
11) for data management. A thematic analysis approach30 was used to code the dataset and identify 
themes, with the Model of Pathways to Treatment31,32 providing a framework to understand the 
pathways to diagnosis, as recommended by the Aarhus Statement.33 One researcher read and coded 
all transcripts as the interviews progressed, comparing experiences across the whole cohort and 
between cancers. A subset of transcripts were reviewed by four members of the research team, with 
final themes discussed and agreed throughout the analysis.
Results
Between May 2016 and October 2017, newly diagnosed patients were discussed at weekly regional 
multidisciplinary team meetings, with eligible patients (n = 321) identified and approached by the 
two recruiting hospitals. A total of 127 patients completed the questionnaire (40% recruitment rate), 
the majority (n = 109, 86%) within 6 weeks of diagnosis. Participants included 102 with oesophageal 
cancer and 25 with gastric cancer. Twenty- seven participants were invited for interview, and 26 
interviews were completed (one non- responder to invite), all within 10 weeks of diagnosis. Participant, 
healthcare, and disease characteristics are presented in Table 1.
Comparing survey responders with non- responders, age was significantly associated with 
participation (Pearson’s χ2 = 8.043, P = 0.018), with fewer participants aged <60 years (9.3% versus 
18.5%) and more aged 60–74 years (61.2% versus 46.6%). There was no difference based on sex.
Study data were used to explore participants’ knowledge of oesophageal and gastric cancer, 
understanding of heartburn (a key symptom in awareness campaigns), appraisal of symptoms, and 
help- seeking. In the discussion of each theme, survey and interview data are presented using a 
narrative synthesis approach,34 with a textual account of relevant findings from both data sources. 
Interview quotations are presented verbatim and contextualised with the participant ID, sex, age 
group (<60 years, 60–74 years, or ≥75 years), and cancer type.
Knowledge of oesophageal and gastric cancer
Participants reflected on their limited knowledge of oesophageal and gastric cancer and the associated 
symptoms: 'I didn’t know much about stomach cancer' (P22: male, aged 60–74 years, gastric); 'I’ve 
never heard of it, I’ve never heard of the oesophagus even' (P01: male, aged <60 years, oesophageal). 
One participant recalled hearing the radio advertisement for the Be Clear on Cancer campaign,7 which 
highlighted dysphagia, while another participant read about the symptom in a magazine. Despite 
experiencing this symptom, these participants initially did not act on the advice to seek help:
'I heard the advert and I took no notice of it.' 
 (P04: male, aged <60 years, oesophageal)
'I’d read it in a magazine […] I thought, "Oh yes, a lot of that relates to me" but still you think, 
"No […] carry on, you’re fine" you know, which I’ve done for the last 18 months.'  
(P03: female, aged 60–74 years, oesophageal)
Based on symptoms reported in the questionnaire (Box 1A), 74 (58%) participants experienced 
dysphagia before diagnosis, although this was primarily participants with oesophageal cancer (n = 66, 
65%) compared with gastric cancer (n = 8, 32%). Fifty- two (41%) participants experienced heartburn, a 
major symptom of the Be Clear on Cancer campaign (‘heartburn most days for three weeks or more’).7 
Of these participants, most reported heartburn some of the time (n = 41, 79%), with only 11 (21%) 
participants experiencing it more frequently (all or most of the time).
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Table 1 Participant, healthcare, and disease characteristics
Survey participants
(n = 127)a
Interview participants
(n = 26)a
Age, years
Median	(range) 71 (44–96) 69.5 (55–88)
<60 12 (9.4b) 3 (11.5)
60–74 78 (61.4b) 12 (46.2)
≥75 37 (29.1b) 11 (42.3)
Sex
Male 102 (80.3) 18 (69.2)
Female 25 (19.7) 8 (30.8)
Cancer type
Oesophagealc 102 (80.3) 15 (57.7)
Gastricd 25 (19.7) 11 (42.3)
Ethnic group
White 124 (97.6) 26 (100.0)
Other 3 (2.4) 0 (0.0)
Region
East 77 (60.6) 13 (50.0)
North	East 50 (39.4) 13 (50.0)
Comorbidities
Arthritis 38 (29.9) 13 (50.0)
Cancer	—	other	than	O/G 22 (17.3) 5 (19.2)
Heart	disease 17 (13.4) 2 (7.7)
Lung	disease 13 (10.2) 2 (7.7)
Anxiety	or	depression 13 (10.2) 2 (7.7)
Barrett’s	or	reflux	disease 10 (7.9) 1 (3.8)
Any	of	the	above 72 (56.7) 16 (61.5)
OTC medication
None 79 (62.2) 17 (65.4)
Antacid	or	similar 30 (23.6) 7 (26.9)
Other 8 (6.3) 1 (3.8)
Reported GP consultations
Nonee 13 (10.2) 6 (23.1b)
1 56 (44.1) 10 (38.5b)
2 35 (27.6) 4 (15.4b)
≥3 21 (16.5) 6 (23.1b)
Referral route
Urgentf 88 (69.3) 16 (61.5)
Routine 19 (15.0) 6 (23.1)
Other 9 (7.1) 2 (7.7)
continued on next page
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Survey participants
(n = 127)a
Interview participants
(n = 26)a
Urgent referral based on GP consultations
Nonee 8 (6.3) 2 (7.7b)
1 41 (32.3) 8 (30.8b)
2 24 (18.9) 2 (7.7b)
≥3 15 (11.8) 4 (15.4b)
Cancer stage pre- treatment
I/II 59 (46.5) 12 (46.2)
III/IV 64 (50.4) 14 (53.8)
aValues	are	n	(%)	unless	otherwise	stated.	Missing	data	not	included	bPercentages	subject	to	rounding	error.	
cTumours	located	in	the	upper	or	middle	or	lower	oesophagus	and	gastro-	oesophageal	junction,	including	
both	adenocarcinomas	and	squamous	cell	carcinomas.	dTumours	located	in	the	cardia,	fundus,	body,	antrum,	
or	pylorus.	ePatient	referred	opportunistically,	that	is,	having	attended	primary	care	for	another	reason.	fUrgent	
referral	is	the	2-	week	wait	suspected	cancer	pathway.
O/G	=	oesophageal	or	gastric.	OTC	=	over	the	counter.
Table 1 Continued
Understanding heartburn
When asked about heartburn experience, many participants described it as a burning sensation or 
acid taste, while some referred to mild pain:
'I know what heartburn is and it’s a burning sensation.' 
 (P18: male, aged ≥75 years, oesophageal)
'[Heartburn] is just this, I don’t know, rotten taste really […] it’s acid.' 
 (P26: female, aged ≥75 years, gastric)
'Mild pain to the right of my chest, which is traditionally the heartburn area, as I understand it.' 
 (P17: male, aged 60–74 years, oesophageal)
These symptoms were also ascribed to reflux and indigestion — 'it really does have that kind 
of burning feel about it when I had reflux' (P06: male, aged <60 years, oesophageal) — with some 
participants using ‘heartburn’, ‘reflux’, and ‘indigestion’ interchangeably: 'I get discomfort … with the 
indigestion, and heartburn, and my tummy sometimes used to feel … a bit sore' (P22: male, aged 60–
74 years, gastric). However, some participants understood reflux and indigestion in relation to other 
symptoms, such as burping and regurgitation, along with severe pain associated with indigestion, 
suggesting the meanings of these terms may differ between participants:
'It started with reflux […] so a bit like a burp down here and eventually that translates into 
going to the toilet and having to be sick.' 
 (P18: male, aged ≥75 years, oesophageal)
'[Reflux] was very definitely something that was sort of coming back up […] into my throat.' 
 (P05: female, aged 60–74 years, gastric)
'It did feel like indigestion […] but was quite painful and seemed to spread […] it was actually 
causing some pain in my head as well.' 
 (P06: male, aged<60 years, oesophageal)
One participant described how he had 'a couple of issues with regurgitation' (P25: male, aged 
60–74 years, gastric), yet did not attribute this to reflux as he believed that heartburn and indigestion 
were the symptoms of reflux: 'I wasn’t getting the general symptom of acid reflux, which is indigestion 
and heartburn.' Figure  1A illustrates participants’ understanding of symptoms and the perceived 
overlap between the conditions, in comparison with clinical perspectives presented in Figure 1B.
Based on questionnaire reported symptom experience, almost half of the total cohort (n = 62, 
49%) reported regurgitation, while 45 (35%) participants experienced upper abdominal pain before 
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Figure 1 Participant	and	clinical	perspectives	of	heartburn,	reflux,	and	indigestion.35–37
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diagnosis. When combining participant experience of these symptoms with those reporting a burning 
sensation, 89 (70%) participants experienced at least one of these symptoms.
Symptom appraisal
Most participants were symptomatic, with 116 (91%) participants experiencing at least one symptom, 
and 110 (87%) reporting multiple symptoms before diagnosis. There were variations in the most 
commonly reported symptoms between cancers, with fatigue or tiredness the most common symptom 
experienced by participants with gastric cancer (n = 20, 80%), and dysphagia the most common for 
oesophageal participants (n = 66, 65%).
Symptoms were often normalised in the early stages of appraisal, with participants unconcerned by 
initial changes, attributing them to other factors including age, work, and lifestyle:
'You’re […] over 60 and you’re doing a job like that, and you’re thinking, "Well, I’m getting 
older now, so I’m bound to be feeling a bit more tired".' 
 (P22: male, aged 60–74 years, gastric)
'I just noticed that I was having trouble getting food to go down my oesophagus […] I was 
doing the 5+2 dieting so I thought maybe it was some peculiar effect.' 
 (P06: male, aged <60 years, oesophageal)
Heartburn, reflux, and indigestion were also viewed as a normal part of everyday life, with this 
view reinforced by advertisements for antacids, promoting over- the- counter medication to manage 
symptoms:
'A bit of indigestion, if you will, nothing drastic, more indigestion than anything, and I didn’t 
bother about it, no reason.' 
 (P11: male, aged 60–74 years, oesophageal)
'You'd say to somebody, “I've got acid reflux“ [...] everybody in the world has acid reflux.' 
 (P18: male, aged ≥75 years, oesophageal)
'You see the adverts on the television for Gaviscon and Rennies […] you get the people with 
the brushes swishing out the inside of the stomach […] and that very satisfied look on a 
person’s face, and that’s what you think heartburn is all about.'  
(P17: male, aged 60–74 years, oesophageal)
Thirty- eight (30%) participants reported using over- the- counter medication to manage symptoms, 
primarily antacids or similar (n = 30, 24%), with interview participants describing their use in attempting 
to ease indigestion. Some were successful in initially managing their symptoms, while others found 
these medications ineffective:
'I was trying to cure it myself like with Gaviscon and other patent medicines which didn’t work 
[…] I’d swallow it and it’d just come straight back up again.'  
(P08: male, aged ≥75 years, oesophageal)
'I bought the double tablets for them and when I was going down the road for a walk I used to 
shove a couple in my pocket just in case indigestion came on.'  
(P23: female, aged ≥75 years, gastric)
Unusual symptoms
Unlike the more ‘everyday’ symptoms that participants could normalise, some symptoms represented 
a deviation from what was normal or acceptable for participants, and were thus regarded as unusual. 
Such bodily changes prompted participants to consider these a possible ‘symptom of something’. 
The labelling of symptoms as ‘unusual’ differed between participants. This was particularly noticeable 
for weight loss; some participants were concerned by the change in their normal physical state, while 
others viewed it in a positive way, even when the amount lost was considerable and often unexpected:
'I’ve always had quite strong legs, because I’ve always exercised […] I started to notice that my 
legs were getting thinner, and I just thought, "That’s strange." Then my arms […] I noticed I 
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'It was just like clear phlegm, just really weird, cos it was just clear; no food in it or anything.' 
	(P01:	male,	aged	<60	years,	oesophageal)	
'It wasn’t so much the meat it was just like thick water, like wallpaper paste.' 
	(P04:	male,	aged	<60	years,	oesophageal)	
'It was just this froth, like an enormous amount of spit.' 
	(P08:	male,	aged	≥75	years,	oesophageal)	
'I mean it used to be that thick at times I couldn’t get it out of my throat, I had to put my fingers in my mouth and get hold of it and drag it out.' 
	(P12:	male,	aged	≥75	years,	oesophageal)	
'That was like all stringy stuff, you know. Clear yeah. But you know there seemed yards and yards of it coming out.' 
	(P13:	female,	aged	≥75	years,	oesophageal)	
'Very quickly turning into not being able to eat or hardly drink without quite dramatic vomiting,	which was primarily just stringy goo.' 
	(P17:	male,	aged	60–74	years,	oesophageal)	
'It’s this gooey phlegmy type thing that's almost elastic, it sort of stretches from my mouth into the toilet, if you know what I mean. It's odd stuff 
and it's obviously what the stomach produces, I think.' 
	(P18:	male,	aged	≥75	years,	oesophageal)	
'I had a lot of, well, I call it phlegm, but it wasn’t. It was very, very white and very clear, and with a lot of bubbles in it.' 
	(P25:	male,	aged	60–74	years,	gastric)
Box 2  Quotes illustrating unusual nature of vomiting
was starting to lose muscle content.'  
(P22: male, aged 60–74 years, gastric)
'I looked at myself in the mirror and it didn’t look like me, I was so slim, and this 12–14 jumper 
fit me absolutely perfect […] I must have lost about two stone without even realising.' 
 (P02: female, aged ≥75 years, oesophageal)
Symptoms were also recognised as unusual when the experience did not match the participant’s 
understanding of how the symptom should present. Notably, half the oesophageal participants 
interviewed, and one gastric participant, described the unusual nature of their sickness, based on the 
symptom differing from what was expected when vomiting:
'It weren’t a normal sick. To me, sick, it’s contents of your stomach, innit? What we call a 
"pavement pizza" but it weren’t like that.' (P01: male, aged <60 years, oesophageal)
Instead of experiencing ‘normal’ vomiting, participants described bringing up ‘stringy goo’, with 
the consistency likened to other bodily fluids such as spit or phlegm (Box 2). Many also commented 
on the quantity of fluid coming up and the difficulties experienced when trying to manage it:
'Well like spit in my mouth […] it just kept coming and that was sort of slimy, you know.' 
 (P13: female, aged ≥75 years, oesophageal)
‘It used to be that thick at times I couldn’t get it out of my throat, I had to put my fingers in my 
mouth and get hold of it and drag it out […] it could be six inches long sometimes.‘ 
 (P12: male, aged ≥75 years, oesophageal)
This type of experience encouraged participants to consider seeking help as they were unable 
to find an explanation for their symptoms: 'I didn’t know what the devil it was' (P18: male, aged ≥75 
years, oesophageal).
symptom progression and severity
Help- seeking was also considered when symptoms persisted over a period of time without resolving 
or worsened, increasing in frequency and/or intensity. This was particularly apparent for dysphagia:
'Clearly it wasn’t going away and was although not getting […] rapidly worse, clearly wasn’t 
getting any better and probably was getting worse.' 
 (P06: male, aged <60 years, oesophageal)
Humphrys E et al. BJGP Open 2020; DOI: 10.3399/bjgpopen20X101001
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Figure 2 First	symptom	presented	to	the	GP	compared	with	symptom	experience	before	diagnosis,	stratified	by	cancer	type.
'Things were starting to get worse, a lot worse, and then as I say, that day when I couldn’t 
drink the coffee I thought, "That’s it, I’ve had enough. I can’t carry on any longer".' 
 (P01: male, aged <60 years, oesophageal)
Others had the experience of a sudden symptom that felt overwhelming. This was often in relation 
to vomiting or severe pain, based on the shock of suddenly being sick or the intensity of the pain:
'I had this overwhelming feeling of sickness and I thought, "I’m gonna be sick", and I was 
actually sick, which shocked me ‘cause it just came out of the blue.' 
 (P05: female, aged 60–74 years, gastric)
'I swallowed it and it was initially fine and then it wasn’t fine and I was just in absolute agony 
for half an hour, doubled over in agony, my tears were pouring out of my eyes because I felt so 
much pain.' 
 (P17: male, aged 60–74 years, oesophageal)
As symptoms progressed, participants found that daily activities were increasingly affected and 
their bodily changes became more apparent, to them and to those around them:
'Sunday morning, I’m sitting in here, [wife] asked me to go and do something, and I couldn’t 
do it. I couldn’t go up the stairs. I got to the top of the stairs and I couldn’t breathe.' 
 (P19: male, aged 60–74 years, gastric)
  11 of 15
Research
Humphrys E et al. BJGP Open 2020; DOI: 10.3399/bjgpopen20X101001
Help-seeking in primary care
Most participants (n = 112, 88%) sought help in primary care, having recognised the need for additional 
support in managing their symptoms: 'I thought “I can’t deal with it the way I am dealing with it so 
I need some help”.' (P16: male, aged 60–74 years, gastric). This often followed an extended period 
of appraising and managing symptoms, with participants reporting a median patient interval of 79.5 
days (range 1–712 days). Dysphagia was the most common symptom first presented (n = 44, 35%), 
although, as with the general experience of this symptom, this was driven almost entirely by those 
with oesophageal cancer (n = 43, 42%):
'I just felt it go all the way down from top to bottom […] you don’t normally feel the food 
go down, it just goes down, and this time I felt it go all the way down quite sharpish.' 
 (P11: male, aged 60–74 years, oesophageal)
Other symptoms were less frequently presented as the first symptom, despite their reported 
prevalence. For example, fatigue or tiredness was presented by only two gastric participants (8%), 
despite being the most common symptom for gastric participants before diagnosis (n = 20, 80%) and 
experienced by 72 (57%) participants across the cohort (Figure 2):
'I said, "I’m absolutely worn out. I’ve got no strength. I can hardly walk. I just feel all in. I can't 
even get up the stairs, I’m out of breath, I’m puffing and panting. And I’m not like that".' 
 (P24: male, aged ≥75 years, gastric)
Discussion
Summary
This study used a survey and interviews to explore early symptom experience of oesophageal and 
gastric cancer from the perspective of newly diagnosed patients. Knowledge of these cancers was 
limited and symptoms were often ‘normalised’ or self- managed initially. Participants had multiple 
symptoms before diagnosis, with some variations in symptom experience between cancers. Despite 
heartburn being flagged by national campaigns as a key symptom, interviews highlighted how this 
term may not resonate with individuals. Participants often referred instead to reflux or indigestion 
when describing symptoms associated with heartburn, which may impact the interpretation of 
symptoms between patients and GPs. Those symptoms acknowledged as unusual, prolonged, or 
severe were more likely to be recognised as ‘symptom(s) of something’. As symptoms progressed, 
help- seeking was considered, with most participants consulting in primary care, although participants 
may not present all symptoms at the initial consultation, making it challenging for GPs to distinguish 
between benign disorders and suspected cancer.
Strengths and limitations
The recruitment of 40% of eligible participants to the survey was a strong response rate considering 
the difficult time at which patients were approached, and is higher than the 19.5%–24% response 
rates observed in similar studies.19–21 Response to the interviews was positive with a broad range of 
participants recruited, allowing for in- depth exploration and comparison of experiences. A strength 
of the study design and analysis was that it combined survey and interview methods, and was guided 
by a conceptual framework, as recommended in early diagnosis research.33
The main limitation was the small sample size for survey analysis. Recruiting additional hospitals 
or sending questionnaire reminders could have increased participation; however, resources were 
limited for hospital recruitment and reminders may have caused patient distress at an already difficult 
time. Across the survey cohort, females, younger patients, and non- white ethnic groups were under- 
represented. These patients may have different experiences; therefore, generalisability of the results 
is limited. Patients with gastric cancer were also under- represented in the survey; however, almost 
half of the interview participants were diagnosed with gastric cancer, allowing in- depth exploration of 
their experiences and comparison with participants with oesophageal cancer. As the study recruited 
participants retrospectively, symptom reporting and narratives may have been subject to post hoc 
rationalisation; however, the data reflect reported participant experiences and perspectives.
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Comparison with existing literature
Existing literature is primarily based around quantitative methods, with the exception of a recently 
published study exploring symptom appraisal with 14 participants diagnosed with oesophageal cancer 
in Scotland (2012–2015).38 Interviews were conducted within 9 months of diagnosis, with the authors 
finding participants had limited knowledge of oesophageal cancer, initially appraising symptoms in 
the context of normal bodily functions until symptoms changed or worsened. This reflects findings 
in the current study, and resonates with research across other cancers, where subtle or intermittent 
symptoms are often not considered serious25–27,39–41 and initial bodily changes are attributed to benign 
causes.39,42–45 Another study explored the use of over- the- counter medication in Scotland with 25 
patients diagnosed with lung (n = 14), colorectal (n = 4), or oesophago- gastric (n = 7) cancer in the 
preceding 12 months.46 More than half of the participants self- selected over- the- counter medications 
to initially manage symptoms, a finding similar to the current study, in which a third of participants 
used widely available medicines before consulting a healthcare professional. The findings identified 
a longer patient interval compared with previous studies (almost 3 months compared with up to 3 
weeks),5 suggesting that current data may underestimate the period before diagnosis.
Previous studies using primary care medical records47–49 have explored symptoms as risk factors 
for oesophageal and gastric cancer. Stapley et al identified a 4.8% risk of cancer for patients with 
dysphagia and an increased risk for other symptom combinations such as epigastric pain with weight 
loss (4.2% risk).47 Dysphagia was primarily associated with oesophageal cancer, reflecting a previous 
study by Irving et al comparing the prevalence of this symptom between oesophageal and gastric 
cancer (77% versus 32%).50 The current findings also reflect this, with dysphagia primarily attributable 
to participants with oesophageal cancer. It is important to recognise other symptom combinations 
for gastric cancer patients, although the findings show that patients may not report all symptoms; 
therefore, risk models based on primary care records may not accurately reflect symptom experience. 
A novel finding from this study relates to the unusual sickness experienced by half of the interviewees 
with oesophageal cancer. Understanding the nature of symptoms, such as vomiting compared with 
'stringy goo', may be important when assessing symptoms in primary care.
While symptom awareness campaigns are important for encouraging patients to seek help in 
primary care, the findings suggest that the key messages of the 2015 National Be Clear on Cancer 
campaign,7 focusing on frequent heartburn and dysphagia, may not have resonated with patients. 
As described, swallowing difficulties were rarely mentioned by gastric participants, suggesting that 
the campaign message may have failed to pinpoint relevant experiences for this group. In addition, 
only one- fifth of participants reported experiencing frequent heartburn and participants sometimes 
described symptoms of heartburn yet identified them as reflux or indigestion, making it difficult to 
relate to the campaign message. This has implications for primary care, where patients use the terms 
heartburn, reflux, or indigestion instead of describing their symptoms, as symptoms associated with 
these conditions may differ between patients.
Implications for research and practice
Future research would benefit from investigating oesophageal and gastric cancers separately, 
to fully understand differences in symptom presentation. It is also important for future awareness 
campaigns to appreciate variations in symptom meanings and interpretation, to reduce potential 
misinterpretation of messages and symptom self- management where healthcare intervention would 
be more appropriate. Engaging with pharmacies and other providers of over- the- counter medication 
to utilise opportunities to encourage help- seeking could also prompt patients to consult sooner.
Patients often seek help following long periods of appraisal and may not present all relevant 
symptoms at their first consultation. Individual descriptions and terminology used by patients for upper 
gastrointestinal symptoms may hold different meanings to those understood by clinicians, increasing 
the possibility of misinterpretation or normalisation by the GP. This highlights the importance of careful 
exploration of the meaning of commonly used terms, such as reflux and indigestion, and ensuring that 
all relevant symptoms are identified during the consultation to avoid missed opportunities for earlier 
referral and diagnosis.
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